Home › Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate
 

Keywords :   


Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

2015-02-03 14:17:18| Agriculture - Topix.net

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

Tags: trial drug phase patient

Category:Agriculture and Forestry

Latest from this category

All news
22.11Trump expected to tab Kelly Loeffler for Secretary of Agriculture
22.11Hay supply is likely up, but winter feed costs still matter
22.11Future plans for US SHIP and USDA's role explored
22.11Strategy for increasing feed efficiency for cows
22.11Top 3 myths of cattle marketing
22.11Carcass management workshop gets pork producers FAD prepared
22.11Are we close to eliminating Mycoplasma hyopneumoniae from the U.S. swine herd?
22.11Costa to challenge Scott for top House Agriculture Democrat role
Agriculture and Forestry »
23.11
23.11 85
23.11DANCEWITHDRAGON2 811
23.11 N5000VSE
23.11EZY POWER EDIT6
23.11RR4
23.1126.5 HG
23.11VISSLA
More »